Portal de Periódicos da CAPES

Tissue-selective 1,25-dihydroxyvitamin D3 resistance: Novel applications of calciferols

1988; Oxford University Press; Volume: 3; Issue: 5 Linguagem: Inglês

10.1002/jbmr.5650030502

1523-4681

Stephen J. Marx, Julia Bársony,

Growth Hormone and Insulin-like Growth Factors

Journal of Bone and Mineral ResearchVolume 3, Issue 5 p. 481-487 Editorial Tissue-selective 1,25-dihydroxyvitamin D3 resistance: Novel applications of calciferols Stephen J. Marx M.D., Corresponding Author Stephen J. Marx M.D. Mineral Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MDBuilding 10, Room 9C-101 National Institutes of Health Bethesda, MD 20892xsSearch for more papers by this authorJulia Barsony, Julia Barsony Mineral Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MDSearch for more papers by this author Stephen J. Marx M.D., Corresponding Author Stephen J. Marx M.D. Mineral Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MDBuilding 10, Room 9C-101 National Institutes of Health Bethesda, MD 20892xsSearch for more papers by this authorJulia Barsony, Julia Barsony Mineral Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MDSearch for more papers by this author First published: October 1988 https://doi.org/10.1002/jbmr.5650030502Citations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW 1987 Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235: 1214–1217. 10.1126/science.3029866 CASPubMedWeb of Science®Google Scholar 2 Burmeister JK, Maeda N, DeLuca HF 1988 Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. Proc Natl Acad Sci USA 85: 1005–1009. Google Scholar 3 Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85: 3294–3298. 10.1073/pnas.85.10.3294 CASPubMedWeb of Science®Google Scholar 4 Gandrillon O, Jurdic P, Benchaibi M, Xiao J-H, Ghysdael J, Samarut J 1987 Expression of the v-erbA oncogene in chicken embryo fibroblasts stimulates their proliferation in vitro and enhances tumor growth in vivo. Cell 49: 687–697. 10.1016/0092-8674(87)90545-9 CASPubMedWeb of Science®Google Scholar 5 Petkovitch M, Brand NJ, Krust A, Chambon P 1987 A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444–450. CASPubMedWeb of Science®Google Scholar 6 Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240: 889–894. 10.1126/science.3283939 CASPubMedWeb of Science®Google Scholar 7 Tora L, Gronemeyer H, Turcotte B, Gaub M-P, Chambon P 1988 The N-terminal region of chicken progesterone receptor specifies target gene activation. Nature 333: 185–188. 10.1038/333185a0 CASPubMedWeb of Science®Google Scholar 8 Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM 1985 Primary structure and expression of functional human glucocorticoid receptor cDNA. Nature 318: 635–641. 10.1038/318635a0 PubMedWeb of Science®Google Scholar 9 Thompson CC, Weinberger C, Lebo R, Evans RM 1987 Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system. Science 237: 1610–1614. 10.1126/science.3629259 CASPubMedWeb of Science®Google Scholar 10 Pike JW, Sleator N 1985 Hormone-dependent phosphorylation of the 1,25-dihydroxyvitamin D3 receptor in mouse fibroblasts. Biochem Biophys Res Commun 131: 378–385. 10.1016/0006-291X(85)91813-3 CASPubMedWeb of Science®Google Scholar 11 Bishop JE, Hunziker W, Norman AW 1982 Evidence for multiple molecular weight forms of the chick intestinal 1,25-dihydroxyvitamin D3 receptor. Biochem Biophys Res Commun 108: 140–145. 10.1016/0006-291X(82)91842-3 CASPubMedWeb of Science®Google Scholar 12 Binderman I, Somjen D 1984 24, 25-Dihydroxycholecalciferol induces the growth of chick cartilage in vitro. Endocrinology 115: 430–432. 10.1210/endo-115-1-430 CASPubMedWeb of Science®Google Scholar 13 Sher E, Frampton RJ, Eisman JA 1985 Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cells. Endocrinology 116: 971–977. 10.1210/endo-116-3-971 CASPubMedWeb of Science®Google Scholar 14 Hirst M, Felman D 1982 Glucocorticoid regulation of 1,25-dihydroxyvitamin D3 receptors: Divergent effects on mouse and rat intestine. Endocrinology 111: 1400–1402. 10.1210/endo-111-4-1400 CASPubMedWeb of Science®Google Scholar 15 Chen TL, Felman D 1981 Regulation of 1,25-dihydroxyvitamin D3 receptors in cultured mouse bone cells: Correlation of receptor concentration with the rate of cell division. J Biol Chem 256: 5561–5566. CASPubMedWeb of Science®Google Scholar 16 Nakada M, DeLuca HF 1985 The appearance of 1,25-dihydroxyvitamin D3 receptor during chick embryo development. Arch Biochem Biophys 238: 129–134. 10.1016/0003-9861(85)90148-1 CASPubMedWeb of Science®Google Scholar 17 Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF 1979 Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206: 1188–1190. 10.1126/science.505004 CASPubMedWeb of Science®Google Scholar 18 Narbaitz R, Stumpf WE, Sar M, Huang S, DeLuca HF 1983 Autoradiographic localization of target cells for lα,25-dihydroxyvitamin D3 in bones from fetal rats. Calcif Tiss Int 35: 177–182. 10.1007/BF02405028 CASPubMedWeb of Science®Google Scholar 19 Kim YS, Stumpf WE, Clark SA, Sar M, DeLuca HF 1983 Target cells for 1,25-dihydroxyvitamin D3 in developing rat incisor teeth. J Dent Res 62: 58–59. 10.1177/00220345830620011301 CASPubMedWeb of Science®Google Scholar 20 Narbaitz R, Sar M, Stumpf WE, Huang S, DeLuca HF 1981 1,25-Dihydroxyvitamin D3 target cells in rat mammary gland. Horm Res 15: 263–269. 10.1159/000179465 CASPubMedWeb of Science®Google Scholar 21 Stumpf WE, Clark SA, Sar M, DeLuca HF 1984 Topographical and developmental studies on target sites of 1,25(OH)2 vitamin D3 in skin. Cell Tissue Res 238: 489–496. 10.1007/BF00219863 CASPubMedWeb of Science®Google Scholar 22 Provvedini DM, Rulot CM, Sobol RE, Tsoukos CD, Manolagas SC 1987 1α,25-Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes. J Bone Min Res 2: 239–247. 10.1002/jbmr.5650020311 CASPubMedWeb of Science®Google Scholar 23 Stumpf WE, Sar M, Clark SA, DeLuca HF 1982 Brain target sites for 1,25-dihydroxyvitamin D3. Science 215: 1403–1405. 10.1126/science.6977846 CASPubMedWeb of Science®Google Scholar 24 Roodman GD, Ibbotson KJ, MacDonald BR, Kuehl TJ, Mundy GR 1985 1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow. Proc Natl Acad Sci USA 82: 8213–8217. 10.1073/pnas.82.23.8213 CASPubMedWeb of Science®Google Scholar 25 Bettens F, Schlick E, Farrar W, Ruscetti F 1986 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters. J Cell Physiol 129: 295–302. 10.1002/jcp.1041290305 CASPubMedWeb of Science®Google Scholar 26 Munker R, Norman A, Koeffler HP 1986 Vitamin D compounds: Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 78: 424–430. 10.1172/JCI112593 CASPubMedWeb of Science®Google Scholar 27 Smith EL, Walworth NC, Holick MF 1986 Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86: 709–714. 10.1111/1523-1747.ep12276343 CASPubMedWeb of Science®Google Scholar 28 Cantley LK, Russell J, Lettieri D, Sherwood LM 1985 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117: 2214–2119. Google Scholar 29 Marx SJ, Liberman UA, Eil C, Gamblin GT, Degrange DA, Balsan S 1984 Hereditary resistance to 1,25-dihydroxyvitamin D. Rec Prog Horm Res 40: 589–615. CASPubMedWeb of Science®Google Scholar 30 Hochberg Z, Borochowitz Z, Benderli A, Vardi P, Oren S, Spirer Z, Heyman I, Weisman Y 1985 Does 1,25-dihydroxy-vitamin D participate in the regulation of hormone release from endocrine glands? J Clin Endocrinol Metab 60: 57–61. Google Scholar 31 Marx SJ, Bliziotes MM, Nanes M 1986 Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol 25: 373–381. 10.1111/j.1365-2265.1986.tb01703.x CASPubMedWeb of Science®Google Scholar 32 Gamblin GT, Liberman UA, Eil C, Downs RW Jr, De-Grange DA, Marx SJ 1985 Vitamin D dependent rickets type II: Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts. J Clin Invest 75: 954–960. 10.1172/JCI111796 CASPubMedWeb of Science®Google Scholar 33 Pike JW, Dokoh S, Haussler MR, Liberman UA, Marx SJ, Eil C 1984 Vitamin D3-resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors. Science 224: 879–891. 10.1126/science.6326262 CASPubMedWeb of Science®Google Scholar 34 Castells S, Greig F, Fusi M, Finberg L, Yasumura S, Liberman UA, Eil C, Marx S 1986 Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone. J Clin Endocrinol Metab 63: 252–256. 10.1210/jcem-63-1-252 CASPubMedWeb of Science®Google Scholar 35 Hirst M, Hockman H, Feldman D 1985 Vitamin D resistance and alopecia: A kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J Clin Endocrinol Metab 60: 490–495. 10.1210/jcem-60-3-490 CASPubMedWeb of Science®Google Scholar 36 Liberman UA, Eil C, Marx SJ 1986 Receptor positive hereditary resistance to 1,25-dihydroxyvitamin D: Chromatography of hormone-receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation. J Clin Endocrinol Metab 62: 122–126. 10.1210/jcem-62-1-122 CASPubMedWeb of Science®Google Scholar 37 Liberman UA, Eil C, Marx SJ 1983 Resistance to 1,25-dihydroxyvitamin D: Association with heterogeneous defects in cultured skin fibroblasts. J Clin Invest 71: 192–200. 10.1172/JCI110759 CASPubMedWeb of Science®Google Scholar 38 Perret C, Desplan C, Brehier A, Thomasset M 1985 Characterisation of rat 9-kDa cholecalcin (CaBP) messenger RNA using a compliementary DNA. Absence of homology with 28-kDa cholecalcin mRNA. Eur J Biochem 148: 61–66. 10.1111/j.1432-1033.1985.tb08807.x CASPubMedWeb of Science®Google Scholar 39 Darbre PD, King RJB 1987 Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors. Cell 51: 521–528. 10.1016/0092-8674(87)90121-8 CASPubMedWeb of Science®Google Scholar 40 Marks SC Jr 1987 Osteopetroisis—multiple pathways for the interruption of osteoclast functions. Appl Pathol 5: 172–183. PubMedGoogle Scholar 41 Zerwekh JE, Marks SC Jr, McGuire JL 1987 Elevated serum 1,25-dihydroxyvitamin D in osteopetrotic mutations in three species. Bone Min 2: 193–199. CASPubMedWeb of Science®Google Scholar 42 Lopez-Hilker S, Galceran T, Chan Y-L, Rapp N, Martin KJ, Slatopolsky E 1986. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J Clin Invest 78: 1097–1102. 10.1172/JCI112666 CASPubMedWeb of Science®Google Scholar 43 Brown EM, Wilkson RE, Eastman RC, Pallotta J, Marynick SP 1982 Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. Clin Endocrinol Metab 54: 172–179. 10.1210/jcem-54-1-172 CASPubMedWeb of Science®Google Scholar 44 Korkor A 1987 Reduced binding of [3H] 1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med 316: 1573–1577. 10.1056/NEJM198706183162504 PubMedWeb of Science®Google Scholar 45 MacLaughlin JA, Gange W, Taylor D, Smith E, Holick MF 1985 Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 82: 5409–5412. 10.1073/pnas.82.16.5409 CASPubMedWeb of Science®Google Scholar 46 Eisman JA 1984 1,25-dihydroxyvitamin D3 receptor and role of 1,25-(OH)2D3 in human cancer cells. In: R Kumar (ed.) Vitamin D: Basic and Clinical Aspects. Martinus Nijhoff, Boston, pp. 365–382. 10.1007/978-1-4613-2839-1_14 Google Scholar 47 Halloran BP, DeLuca HF 1981 Appearance of the intestinal cytosolic receptor for 1,25-dihydroxyvitamin D3 during neonatal development in the rat. J Biol Chem 256: 7338–7342. CASPubMedWeb of Science®Google Scholar 48 Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF 1979 Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest 64: 729–736. 10.1172/JCI109516 CASPubMedWeb of Science®Google Scholar 49 Armbrecht HJ 1986 Age-related changes in calcium and phosphorus uptake by rat small intestine. Biochem Biophys Acta 882: 2871–286. Google Scholar 50 Horst RL, Reinhardt TA 1987. The effects of age on occupied and unoccupied intestinal 1,25-dyhydroxyvitamin D receptors in rats (abstract). J Bone Min Res 2 (Suppl 1): 200A. Google Scholar 51 Sakati N, Woodhouse NJY, Niles N, Harfi H, de Grange DA, Marx S 1986 Hereditary resistance to 1,25-dihydroxyvitamin D: Clinical and radiological improvement during high-dose oral calcium therapy. Horm Res 24: 280–287. 10.1159/000180568 PubMedWeb of Science®Google Scholar 52 Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, Bourdeau A, Silver C, Ricour C 1986 Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J. Clin Invest 77: 1661–1667. 10.1172/JCI112483 CASPubMedWeb of Science®Google Scholar 53 Weisman Y, Bab I, Gazit D, Spirer Z, Jaffe M, Hochberg Z 1987 Long-term intracaval calcium infusion therapy in endorgan resistance to 1,25-dihydroxyvitamin D. Am J Med 83: 984–990. 10.1016/0002-9343(87)90666-8 CASPubMedWeb of Science®Google Scholar 54 Bliziotes M, Yergey A, Nanes M, Muenzer J, Viera N, Begley M, Kher K, Marx S 1988 Absent intestinal response to calciferols in hereditary resistance to 1,25-dyhydroxyvitamin D: Documentation and effective therapy with high dose intravenous calcium infusions. J Clin Endocrinol Metab 66: 294–300. 10.1210/jcem-66-2-294 CASPubMedWeb of Science®Google Scholar 55 Key L, Carnes D, Cole S, Holtrop M, BarShavit Z, Shapiro F, Arceci R, Steinberg J, Gundberg C, Kahn A, Anast CS 1984 Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med 310: 409–415. 10.1056/NEJM198402163100701 PubMedWeb of Science®Google Scholar 56 Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ 1984 Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136–2143. 10.1172/JCI111639 CASPubMedWeb of Science®Google Scholar 57 Morimoto S, Onishi T, Imanaka S, Yukawa H, Kozuka T, Kitano Y, Yoshikawa K, Kumahara Y 1986 Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: Report of five cases. Calcif Tissue Int 38: 119–122. 10.1007/BF02556840 CASPubMedWeb of Science®Google Scholar 58 Holick MF, Smith E, Pincus E 1987 Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis. Arch Dermatol 123: 1677–1683. PubMedWeb of Science®Google Scholar 59 Ostrem VK, Tanaka Y, Prahl J, DeLuca HF, Ikekawa N 1987 24- and 26-homo-1,25-dihydroxyvitamin D3: Preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. Proc Natl Acad Sci USA 84: 2610–2614. 10.1073/pnas.84.9.2610 CASPubMedWeb of Science®Google Scholar 60 Abe J, Morikawa M, Miyamoto K, Kaiho S-I, Fukushima M, Miyaura C, Abe E, Suda T, Nishii Y 1987 Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton: A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett 226: 58–62. 10.1016/0014-5793(87)80550-1 CASPubMedWeb of Science®Google Scholar 61 Binderup L, Bramm E 1988 Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37: 889–895. 10.1016/0006-2952(88)90177-3 CASPubMedWeb of Science®Google Scholar 62 Honma Y, Hozumi M, Abe E, Konno K, Fukushima M, Hata S, Nishii Y, DeLuca HF, Suda T 1983 1α,25-dihydroxyvitamin D3 and 1α-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80: 201–204. 10.1073/pnas.80.1.201 CASPubMedWeb of Science®Google Scholar 63 Sly WS, Whyte MP, Sundaram V, Tashian RE, Hewett-Emmett D, Guibaud P, Vainsel M, Baluarte HJ, Gruskin A, Al-Mosawi M, Sakati N, Ohlsson A 1985 Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 313: 139–145. 10.1056/NEJM198507183130302 CASPubMedWeb of Science®Google Scholar Citing Literature Volume3, Issue5October 1988Pages 481-487 ReferencesRelatedInformation